Using cutting-edge stem cell technology to model human cardiac diseases

Human-induced pluripotent stem cell (iPSC) technology allows for “clinical trials in-a-dish” because patient characteristics can be maintained in cell culture which provides limitless material for research initiatives. Previously, cardiac diseases were difficult to study due to inherent differences in small animal models as well as barriers to patient biopsies. Today, the advent of stem cell technology provides an exciting research strategy with direct human relevance to cardiac disease.

 

In this talk, we will highlight: